|
|
Volumn 17, Issue 10, 1999, Pages 3362-3365
|
|
Current status of oral anticancer drugs in Japan [3]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACEGLATONE;
ANTINEOPLASTIC AGENT;
BUSULFAN;
CARBOQUONE;
CHLORMADINONE;
CYCLOPHOSPHAMIDE;
DOXIFLURIDINE;
ESTRAMUSTINE;
ETHINYLESTRADIOL;
ETOPOSIDE;
FLUOROPYRIMIDINE DERIVATIVE;
FLUOROURACIL;
FOSFESTROL;
KRESTIN;
MELPHALAN;
MEPITIOSTANE;
MERCAPTOPURINE;
METHOTREXATE;
METHYLTESTOSTERONE;
MITOBRONITOL;
MITOMYCIN;
MITOTANE;
PROCARBAZINE;
RETINOIC ACID;
TAMOXIFEN;
TEGAFUR;
TOREMIFENE;
UFT;
UNINDEXED DRUG;
VINDESINE;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
JAPAN;
LETTER;
MALIGNANT NEOPLASTIC DISEASE;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REIMBURSEMENT;
|
|
EID: 0032887408
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.1999.17.10.3362 Document Type: Letter |
|
Times cited : (12)
|
|
References (11)
|
